Indication

Staphylococcus lung abscess

A Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus*. Read more about Staphylococcus lung abscess

13 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Staphylococcus lung abscess therapies.

Showing 1–9 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with Staphylococcus lung abscess preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Staphylococcus lung abscess.

A Staphylococcus lung abscess is a localized, suppurative pulmonary infection marked by microbial necrosis and cavitation of the lung parenchyma, caused specifically by staphylococcal bacteria, most commonly *Staphylococcus aureus*.

Primarily affecting the lower respiratory tract, this condition frequently develops in hospitalized, post-viral, or immunocompromised individuals, as well as persons with a history of intravenous drug use or aspiration.

Pathophysiologically, the disease process is driven by bacterial virulence factors—including cytolytic toxins and necrotizing enzymes—that induce severe tissue destruction, purulent liquefaction, and abscess formation via direct parenchymal invasion or hematogenous seeding from distant bacteremia or septic emboli.

Clinically, it manifests as persistent fever, productive cough with purulent sputum, chest pain, and air-fluid cavitary lesions visible on thoracic imaging.

Personalize your experience

Follow Staphylococcus lung abscess and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it